Clobazam
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
31722-641 -
Package NDC
31722-641-12 -
Application number
ANDA209796 -
SPL ID
556132d3-7f61-e679-e063-6394a90a4528 -
SPL set ID
c9b51794-3cfa-4a34-b5bb-d523b5798c17 -
UNII
2MRO291B4U -
RxCUI
1366192
What the source publishes
- Labeler
- Camber Pharmaceuticals, Inc.
- Active ingredients
- Clobazam
- Form
- SUSPENSION
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Clobazam",
"splId": "556132d3-7f61-e679-e063-6394a90a4528",
"labels": [
{
"setId": "c9b51794-3cfa-4a34-b5bb-d523b5798c17",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c9b51794-3cfa-4a34-b5bb-d523b5798c17",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c9b51794-3cfa-4a34-b5bb-d523b5798c17"
}
],
"routes": [
"ORAL"
],
"labeler": "Camber Pharmaceuticals, Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "1 BOTTLE, GLASS in 1 CARTON (31722-641-12) / 120 mL in 1 BOTTLE, GLASS",
"package_ndc": "31722-641-12",
"identifierStatus": "well-formed",
"marketing_start_date": "20200224"
}
],
"productId": "31722-641_556132d3-7f61-e679-e063-6394a90a4528",
"useDomain": "unknown",
"dosageForm": "SUSPENSION",
"productNdc": "31722-641",
"deaSchedule": "CIV",
"genericName": "Clobazam",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "CLOBAZAM",
"strength": "2.5 mg/mL"
}
],
"applicationNumber": "ANDA209796",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20200224",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175694",
"M0002356",
"N0000182137",
"N0000185506"
],
"upc": [
"0331722641128"
],
"unii": [
"2MRO291B4U"
],
"rxcui": [
"1366192"
],
"spl_set_id": [
"c9b51794-3cfa-4a34-b5bb-d523b5798c17"
],
"pharm_class_cs": [
"Benzodiazepines [CS]"
],
"pharm_class_epc": [
"Benzodiazepine [EPC]"
],
"pharm_class_moa": [
"Cytochrome P450 2D6 Inhibitors [MoA]",
"Cytochrome P450 3A4 Inducers [MoA]"
],
"manufacturer_name": [
"Camber Pharmaceuticals, Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:31722-641_556132d3-7f61-e679-e063-6394a90a4528"